Stanford Medicine News
Precision Health
Read about Stanford Medicine's vision for leading the biomedical revolution.
-
Researchers develop urine test for bladder cancer
Two researchers at the School of Medicine have developed a highly sensitive urine test for more easily diagnosing and monitoring bladder cancer, the sixth most common cancer.
-
Brain implant lets people with limb paralysis compose and send emails select videos and even play music just by thinking
New clinical trial results show that people with paralysis who have been equipped with a technologically advanced, baby-aspirin-sized brain implant can learn to directly operate an off-the-shelf computer tablet, just by thinking.
-
Stanford engineers and medical researchers create wireless, battery-free, biodegradable blood flow sensor
The first-of-its-kind sensor measures the flow of blood through an artery and can warn a patient’s doctor remotely if there is a blockage, making it easier for doctors to monitor the success of blood vessel surgery.
-
Steven Artandi tapped to lead stanford cancer institute
Steven Artandi, MD, PhD, the Jerome and Daisy Low Gilbert Professor and professor of medicine and biochemistry, was recently named the new director of the Stanford Cancer Institute.
-
Stanford Children’s Health appoints new president and CEO
Paul King has been selected as the new president and CEO of Lucile Packard Children’s Hospital Stanford and Stanford Children’s Health.
-
Progress, priorities, challenges are focus of State of Stanford Medicine
At this year’s State of Stanford Medicine event, the dean, hospital CEOs and a special guest shared their reflections on the strengths and challenges of the medical center today.
-
Technologies started at Stanford Biodesign have reached more than 1.5 million patients
Stanford Biodesign trainees have developed new medical devices and diagnostics that have been used to help care for more than 1.5 million patients so far.
-
‘Liquid biopsy’ predicts lymphoma therapy success within days
Changes in circulating tumor DNA levels quickly predict how patients with diffuse large B cell lymphoma are responding to therapy, according to a Stanford-led study. Currently, patients wait months for the results.
-
Researchers can forecast risk of deadly vascular condition from genome sequence
By combining genome-sequence information and health records, Stanford scientists have developed a new algorithm that can predict the risk of abdominal aortic aneurysm, and potentially could be used for any number of diseases.
-
Solar-powered heart: Stanford scientists explore using photosynthesis to help damaged hearts
In the ongoing hunt to find better treatments for heart disease, the top cause of death globally, new research from Stanford shows promising results using an unusual strategy: photosynthetic bacteria and light.
-
Researchers identify biomarkers associated with chronic fatigue syndrome severity
Stanford investigators used high-throughput analysis to link inflammation to chronic fatigue syndrome, a difficult-to-diagnose disease with no known cure.
-
Virtual reality system helps surgeons, reassures patients
Stanford Medicine is using a new software system that combines imaging from MRIs, CT scans and angiograms to create a three-dimensional model that physicians and patients can see and manipulate — just like a virtual reality game.
-
Jeffrey and Marieke Rothschild gift establishes Stanford Center for Cancer Cell Therapy
The Stanford Cancer Institute has received a $10 million gift from Silicon Valley entrepreneur Jeffrey Rothschild and his wife, Marieke, to advance research in cancer cell therapy, which is considered the vanguard of cancer treatment today.
-
Stanford's new Center for Health Education could benefit learners worldwide
With its newly established Center, Stanford seeks to improve global health through a new online medical training initiative for people of all skill levels. Charles Prober, MD, the medical school’s former senior associate dean for medical education, is the founding director.
-
Spencer Center for vision research established at Stanford
Mary M. and Sash A. Spencer's philanthropic gift has created a center to help accelerate translational research, recruit faculty, and train the next generation of leaders in vision science.
-
Philanthropic funding to Stanford Medicine supports record high recruitment and diversity among incoming bioscience graduate students
The School of Medicine has set records in its recruitment statistics for doctoral students this year following the implementation of the Biomedical Innovation Initiative, a funding model that encourages graduate students to follow their passion and take risks.
-
Scientists assemble working human forebrain circuits in a lab dish
Stanford University School of Medicine researchers have observed stem-cell-derived nerve cells arising in a specific region of the human brain migrate into another brain region. This process recapitulates what’s been believed to occur in a developing fetus, but has never previously been viewed in real time.
-
Study shows protein in human umbilical cord blood rejuvenates old mice’s impaired learning, memory
Human umbilical cord blood can rejuvenate learning and memory in older mice, according to a study by researchers at the Stanford University School of Medicine.
-
Stanford Cancer Institute Earns Top Cancer Center Designation
The Stanford Cancer Institute has been designated a Comprehensive Cancer Center by the National Cancer Institute, a part of the National Institutes of Health and the world’s leading cancer research organization.
-
Deisseroth to receive Harvey Prize in Human Health
The Harvey Prize, established by industrialist and inventor Leo Harvey, recognizes researchers who have made breakthroughs in science and technology of benefit to humanity. Optogenetics has “revolutionized neurobiology,” the prize administrators wrote.
